News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

NeoGenomics, Inc. (NGNM.OB) Reports Revenue Of $18.2 Million And Adjusted EBITDA Of $1.7 Million For The First Quarter



4/23/2014 6:51:34 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

FT. MYERS, Fla., April 23, 2014 /PRNewswire/ -- NeoGenomics, Inc. , /quotes/zigman/13104278/delayed/quotes/nls/neo NEO +9.28% a leading provider of cancer-focused genetic testing services today reported its results for the first quarter of 2014.

First Quarter 2014 Highlights:

•Test volume growth of 21%

Help employers find you! Check out all the jobs and post your resume.

Read at Market Watch


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES